Trigger Your Own GLP-1 Factory for Better Blood Sugar
Drugs like Ozempic and Wegovy promise better blood sugar with a side effect of weight loss.
Sounds like a win-win, right?
But taking them is like making a deal with the devil.
They can cause significant side effects, and their long-term effects are not known. And to maintain your results, you’ll likely need to take them for the rest of your life.
It’s a hefty price to pay for something your body already makes.
These drugs work by mimicking the GLP-1 hormone that regulates your appetite, blood sugar, and metabolism.
But, believe it or not, you can ramp up your body’s OWN, built-in GLP-1 system—and when you do, you’re on your way to effortless blood sugar control and weight loss.
For years, scientists believed that two kinds of pancreatic cells were responsible for better blood sugar balance:
- Beta cells, which produce insulin to lower blood sugar.
- Alpha cells, which produce glucagon to raise blood sugar to maintain energy during fasting or exercise.
Type 2 diabetes occurs when your beta cells stop making enough insulin to maintain healthy blood sugar levels.
But scientists recently made a discovery that could revolutionize this view and change diabetes treatment forever.
When they blocked glucagon production in alpha cells, something unexpected happened. Instead of the decline in insulin they thought they’d see, the cells shifted resources and dramatically ramped up their GLP-1 output.
This GLP-1 surge directly enhanced insulin release, leading to better blood sugar control.
This suggests that when beta cells can no longer do their job, the body has a backup system for blood sugar regulation.
So how can you make this discovery work for you? Skip the dangerous GLP-1 impostors and enhance your body’s own GLP-1 production instead.
Here’s how:
Prioritize sleep: Poor sleep reduces the release of GLP-1. To improve your sleep quality, maintain a healthy circadian rhythm by getting sunlight exposure first thing in the morning and avoiding artificial light at night.
Focus on your gut: Most GLP-1 is made in the gut. Support beneficial gut bacteria by eating more fiber, probiotics, and prebiotics to increase GLP-1 signaling and stimulate alpha cells.
Move more: Exercise boosts GLP-1 secretion. But what you do doesn’t matter nearly as much as consistency. For example, I start my day with 20 minutes of yoga poses, then fit in regular bouts of endurance exercise, like hiking, biking, or swimming, and resistance training. But even something like yard work can get your heart pumping and work your muscles.
Slash stress: Elevated stress levels interfere with the release of GLP-1. Mindful meditation can help. I use a simple method where I focus on breathing and turn off that ever-present “analyzer” in my head.
Adopt a GLP-1-friendly diet (including this special water): Eat foods that stimulate GLP-1 release, such as high-protein foods, fermented foods, healthy fats, and high-fiber foods. I also eat seasonally and choose mostly organic, whole foods. And I periodically drink deuterium-depleted water, which can improve glucose metabolism and insulin sensitivity. You can buy deuterium-depleted water online or drink spring water that comes from higher elevations or near the poles (like Alaska). This water tends to be lower in deuterium.
Stop eating after sundown: When you stop eating after dark like I do, your body has a higher and more efficient GLP-1 output in response to meals eaten earlier in the day. This aligns your eating with your body’s natural circadian rhythm, which makes your metabolism and insulin response more effective during daylight hours.
If you’re struggling to balance your blood sugar, skip Big Pharma’s lifetime subscription plan. Boost your body’s own GLP-1 instead—it’s natural, drug-free, and won’t cost you your health.
P.S. This potent kitchen secret drops blood sugar 7+ points.
View Sources
Canqi Cui, Danielle C. Leander, Sarah M. Gray, Kimberley El, et al., α cells use both PC1/3 and PC2 to process proglucagon peptides and control insulin secretion. Science Advances, 2025; 11 (38) DOI: 10.1126/sciadv.ady8048
